Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. - Wikidata - wikimedia - TriplyDB

Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool.

Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool.

http://www.wikidata.org/entity/Q36372817

about

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Cell-free circulating tumor DNA in cancer The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines High-throughput droplet digital PCR system for absolute quantitation of DNA copy number The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer Circulating free mitochondrial DNA concentration and its association with erlotinib treatment in patients with adenocarcinoma of the lung Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs.Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis The plasma DNA concentration as a potential breast cancer screening marker.Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.DNA markers in molecular diagnostics for hepatocellular carcinoma.Detection of hypermethylated vimentin in urine of patients with colorectal cancer.Plasma epidermal growth factor receptor mutation analysis and possible clinical applications in pulmonary adenocarcinoma patients treated with erlotinib Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients.Mathematical Modelling and Prediction of the Effect of Chemotherapy on Cancer Cells.Diagnosis of Lung Cancer by Fractal Analysis of Damaged DNA Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls.Comparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: Biological and clinical implications.A high-efficiency superhydrophobic plasma separator.Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.Diagnostic values of vascular endothelial growth factor and epidermal growth factor receptor for benign and malignant hydrothorax.Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.Detection of mutated K-ras DNA in urine, plasma, and serum of patients with colorectal carcinoma or adenomatous polyps.Alu methylation serves as a biomarker for non-invasive diagnosis of glioma Unleashing the power of proteomics to develop blood-based cancer markers.MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer.Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer CHP2 gene expression and quantitation in Egyptian patients with acute leukemia.[Detection and evaluation of EGFR mutation status in serum of patients with advanced non-small cell lung cancer treated with EGFR-TKIs].Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification.

P2860

Q26741204-4F321C58-F708-4FD0-A509-064D0B2E481F Q26748881-12689756-5311-4975-BE2B-224B4973DFB9 Q26750899-3A608956-8A9A-4270-98AB-2DFF0882CF6C Q26825022-FE24E569-CA36-4DC7-82EE-2CAEC79EF5C1 Q27023830-717D0BA5-A93D-47A8-8828-ECD053C3A9E5 Q28251729-6941E316-798B-4B37-B291-A65B945BC421 Q33591586-23773741-FE9B-420E-8F93-636D26E9C69B Q33727597-2F71EEDD-B5D9-4F90-BE37-E5129AB5D74D Q33829668-5217CE9B-9D3A-44F8-845C-864718A2694D Q33868284-92329042-861C-4E0B-A053-6A461D64FEA2 Q34281395-83816D74-F8B1-424A-B164-FA43CF95A233 Q34305528-3C0D2DD6-9D8C-418B-B60F-F997D7DB9792 Q34500700-992D6140-DBA8-425C-8B71-3F5B0DABB63D Q35028065-E23111FC-4240-4B51-9B59-2DDEBAFD4178 Q35099257-36ABA18B-6CAC-4CFC-90C7-8A1BC5A104A6 Q35169299-9A6A2233-AEC1-4C3B-85F2-C3FF6DB14D4F Q35781255-1D20421A-8F39-413B-A5EA-C3AF29ACC4DB Q35951870-6C6E9586-BC63-4110-B171-C3E76272A60E Q35995313-782EC0D6-5DC9-4EC7-BA54-3F37709FCF15 Q35995428-07C2E541-FA87-4AF6-8444-28989931B38A Q36002786-0573ABFE-944B-490F-B69D-27D6FC47AD6A Q36204319-36F480E5-F0BF-4D36-BF9F-C34F48C8F289 Q36464145-AAF0DDA3-D216-4468-8CA1-25F35704910D Q36475875-80C52A3C-7111-4FB4-BBC5-5D6917A2D154 Q36510219-B283B5D9-06BD-4D3E-88A2-631605A87277 Q36600205-8A5A666B-D6BA-4216-922A-872F7E6FBB07 Q36816398-9CF04D1F-7B46-4A83-B138-948F3A148815 Q36872041-13017296-DDC3-4589-9F38-78BE813614C9 Q36983015-2158CC8A-8235-4CCB-83E6-340B03C0EC11 Q37295593-B17EBFBB-6EA0-46B9-98A1-23CE744DB599 Q38055674-A26FED8C-2999-4927-9CE2-0EF396D1C408 Q38599607-C8C42402-49A1-485A-A2FB-D414FE3ABE37 Q38919473-520B4128-2A98-406A-B2C7-04DB988EBE82 Q39577078-A08E72BE-D8F2-4012-B39A-857E21927F25 Q40358645-9A8D7CE1-4930-4876-8B6D-204F4D68C016 Q42360040-03BCD8D3-BE2F-4768-8AF6-019100350A10 Q43097222-02B70506-7487-4AC7-B8CB-9CB06FDC1E62 Q45281573-9C7B4AC5-C9CD-4B54-B788-FC2DD7EC0646 Q50991286-CF21C28D-840D-47B3-BC0D-46A68B9BF434

P2860

Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool.

http://www.wikidata.org/entity/Q36372817

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Circulating cell-free DNA in p ...... screening and prognostic tool.

@ast

Circulating cell-free DNA in p ...... screening and prognostic tool.

@en

type

label

Circulating cell-free DNA in p ...... screening and prognostic tool.

@ast

Circulating cell-free DNA in p ...... screening and prognostic tool.

@en

prefLabel

Circulating cell-free DNA in p ...... screening and prognostic tool.

@ast

Circulating cell-free DNA in p ...... screening and prognostic tool.

@en

P1433

Q36372817-9A9D5822-A36D-49D5-A469-470621BE9BA9

P1476

Q36372817-92CBF007-603B-4EF6-B1B1-FED3A929EB1D

P2093

Q36372817-0AA6D20E-7A26-419A-99C2-D79CB17BB14A

Q36372817-2587A7AE-C7F8-4232-A8B1-ECE8CAC54E37

Q36372817-4F87F1D3-17A6-464F-BB09-018E4C97D8B1

Q36372817-68FE7C74-FB97-4413-8E78-DA99A7B66858

Q36372817-A207DA0B-6AF6-4C93-93C1-D2C02BAE4044

P304

Q36372817-5B294D41-ACB9-479D-94FC-75AD3663D07E

P31

Q36372817-35485D94-CF32-499F-A3D5-643EECFBFE98

P356

Q36372817-2ADB843C-092F-4C6A-85DF-80E8F1828EF2

P407

Q36372817-7EA63D30-8DAE-41BB-A385-4DD45BFA4E06

P433

Q36372817-4493E5A0-5614-4B1C-8F35-A8B3CA4C05D9

P478

Q36372817-B692D3B1-A60B-47DC-99BB-4954509EE298

P577

Q36372817-2275F77C-6452-4C8D-9B51-D701F50CD7F0

P5875

Q36372817-8C4F699D-73AA-461A-9C2F-6CF686F60D15

P698

Q36372817-15E4B214-46FD-4A82-9E75-D595F92BE9E5

P356

CLINCHEM.2005.062893

P1433

Clinical Chemistry

P1476

Circulating cell-free DNA in p ...... screening and prognostic tool.

@en

P2093

Anant Mohan

http://www.w3.org/2001/XMLSchema#string

Ashutosh K Pathak

http://www.w3.org/2001/XMLSchema#string

Manisha Bhutani

http://www.w3.org/2001/XMLSchema#string

Randeep Guleria

http://www.w3.org/2001/XMLSchema#string

Sachin Kumar

http://www.w3.org/2001/XMLSchema#string

P304

1833-1842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1373/CLINCHEM.2005.062893

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7348661

http://www.w3.org/2001/XMLSchema#string

P698

16423903

http://www.w3.org/2001/XMLSchema#string